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Summary
Background The co-existence of allergic conditions, food allergy,
eczema, allergic rhinitis, asthma and anaphylaxis is thought to be increasing.
Analysis of primary healthcare data-sets offers the possibility to advance
understanding about the changing epidemiology of multiple allergic
disorders.
Aim To investigate recent trends in the recorded incidence, lifetime
prevalence and consulting behaviour of patients with multiple allergic
disorders in England.
Methods QRESEARCH is one of the world’s largest national aggregated
health databases containing the records of over nine million patients
(including those who have left or died). Data were extracted on all patients
with a recorded diagnosis of multiple allergic disorders, and annual age–sex
standardized incidence and lifetime period prevalence rates were calculated
for each year from 2001 to 2005.We also analysed the consulting behaviour
of these patients when compared with the rest of the QRESEARCH database
population.
Results The age–sex standardized incidence of multiple allergic disorders
was 4.72 per 1000 person-years in 2001 and increased by 32.9% to 6.28 per
1000 patients in 2005 (p<0.001). Lifetime age–sex standardized prevalence of
a recorded diagnosis of multiple allergic disorders increased by 48.9% from
31.00 per 1000 in 2001 to 46.16 in 2005 (p<0.001). Over this period, the mean
consultation rate to general practitioners for these patients increased from
4.68 to 4.90 consultations per person per year.
Conclusions Recorded incidence and lifetime prevalence of multiple
allergic disorders in England have increased substantially in recent years.
Introduction
A recent review of UK epidemiological data has
revealed that there has been an inexorable rise
in the prevalence of allergic disorders.1 Allergic
pathophyisiology can cause a spectrum of
diseases in individuals, which may vary in sever-
ity. Atopy – a tendency to produce the IgE anti-
body in response to low doses of aeroallergens –
is known to increase risk of developing allergic
DECLARATIONS
Competing interests
JHC is Director of
QRESEARCH (a
not-for-profit
organization owned
by the University of
Nottingham and
EMIS, commercial
supplier of computer
systems for 60% of
GP practices in the
UK). CS, JN and AS
have no competing
interests
Funding
NHS Health and
Social Care
Information Centre
Ethical approval
Ethics approval was
not required as this
analysis was
conducted using
only anonymized
data
Guarantor
JHC
Contributorship
AS, JHC and JN
were involved in
designing the study
RESEARCH
J R Soc Med 2008: 101: 558–563. DOI 10.1258/jrsm.2008.080196558
disorders such as food allergy, atopic eczema/
dermatitis, allergic rhinitis and asthma.2 Data from
blood measurements taken as part of the Health
Survey for England in 2001 revealed that 42% of
boys and 24% of girls aged 11–15 years were sensi-
tive to the house dust mite (HDM) allergen
(R0.4kU/l HDM specific IgE)3 indicating the very
high proportion of young people who are at high
risk of manifesting allergic problems.
The presence of one allergic disorder signifi-
cantly increases the risk of developing other
allergic disorders affecting different organ sys-
tems.4,5 This has been attributed to the shared pre-
disposition and mechanism for development of
these diseases, whereby an immunological re-
sponse to environmental allergens is driven by
type 2 T cell cytokines.6 Both patients and health-
care providers find managing multiple allergies
to be particularly problematic, with patients
often requiring referrals to a number of different
specialists.7
The Health Survey for England (HSE 1995 to
1997) found that 11% of children (2–15 years),
10% of young adults (16–44 years) and 5% of
older adults (45+years) experienced multiple
allergic disorders.1 While such survey data pro-
vide useful information on variations in period
and lifetime prevalence of self-reported diagnoses
of allergic disorders, particularly in children and
adolescents, there are relatively little reliable
national data describing clinician-diagnosed dis-
ease prevalence; furthermore very few data exist
on the overall population trends over time for all
ages.
Exploitation of large national healthcare data-
sets, with their key strengths of large numbers and
representative data, offers an important oppor-
tunity to develop insights into the epidemiology of
multiple allergic disorders.8 Studying primary
care databases provides a window onto overall
national trends – something that is not possible
with large scale surveys such as the International
Study of Allergies and Asthma in Childhood
(ISAAC), which has studied only children,9 and
the European Community RespiratoryHealth Sur-
vey (ECRHS), which has surveyed only adults.10
Large primary care data-sets, recording infor-
mation at the point at which the majority of
patients with multiple allergic disorders are likely
to be managed does, however, offer an important
opportunity to study changing patterns of disease.
Building on previous work,11–13 we sought to de-
scribe recent trends in the primary care diagnosis
of patients with multiple allergic disorders in
England.
Methods
Version 10 of the QRESEARCH database was used
for these analyses. This database contains rep-
resentative anonymized aggregated health data
derived from 525 general practices throughout the
UK.9 Data were available for the period 1 January
1999–31 December 2005, these comprising of over
nine million individual patients who collectively
contributed over 30 million patient-years of obser-
vation. The method used to collect primary care
data for the QRESEARCH database has been
previously described.11
Patients were included in an analysis year if
they were registered for the entire year of study.
Patients with incomplete data (i.e. temporary resi-
dents, newly registered patients and those who
joined, left or died during the study year) were
excluded. Patients were considered to have an
allergic disorder if they had a relevant computer-
recorded diagnostic Read code (see below) in their
electronic health record during the time period of
interest.
Incidencewas defined as the number of patients
with a new case of having multiple allergic con-
ditions diagnosed in a specific year, with the
denominator being the number of patient-years of
observation (calculated from the number of
patients registered with practices and their length
of registration). Lifetime prevalence was defined
as the number of people having multiple allergic
conditions ever recorded on at least one occasion
in the GP records; the denominator used to calcu-
late the lifetime prevalence rate was the number of
patients registered with the study practices.
Definitions
An allergic condition was defined as patients who
have the following: peanut allergy (SN582),
eczema (M11.., M111., M113–4, M11z, M12z and
below), allergic rhinitis (H17 and below, H18.,
Hyu21 and Hyu22), asthma (Read code H33 and
below) or anaphylaxis (SN50 and below, SP34).
Statistical methods
Because of known age and sex variations, rates of
disease and prescribing were standardized by sex
and five-year age bands. The mid-year population
estimates for England in each year of study were
used as the reference population. These results
were then used to estimate the numbers of people
with multiple allergies in England. The Mantel-
Haenszel 2 test were used to investigate trends
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over time, this analysis being undertaken using
EpiInfo2000 (World Health Organization, Geneva,
Switzerland).
Results
Number of patients with single and
multiple allergic disorders
Between 2001 and 2005, the proportion of regis-
tered patients in QRESEARCH (2,958,366 patients)
recorded as having at least one allergic condition
increased from 18.9% to 24.2%, this representing a
28.0% (95% confidence intervals [CI] 28.0–28.1)
relative increase. During the same period, the pro-
portion of patients with recorded diagnoses of
multiple (i.e. two or more) allergic conditions in-
creased from 3.1% to 4.6% (a 50.0% [95% CI 49.9–
50.1] relative increase).
Age–sex standardization of lifetime
prevalence of patients with multiple
allergic disorders and changes over time
The lifetime prevalence of multiple allergic prob-
lems for 0–14-year-olds was 6.0% (95% CI 5.9–6.1),
5.4% in 15–44-year-olds (95% CI 5.3–5.5) and 3.3%
(95% CI 3.2–3.4) for those aged over 45 years.
Figure 1 shows the lifetime prevalence by age and
sex per 1000 registered patients in QRESEARCH.
Multiple allergic disorders were more common
among women in people aged under 20 years or
over 75 years. In 2005, the lifetime prevalence rate
of multiple allergies was highest in boys aged
10–14 years.
During the five-year study period, the age–sex
standardized lifetime prevalence of multiple
allergic disorders increased by 48.9% (p<0.001)
(Table 1). At the end of 2005, approximately 1 in 22
people had a clinician-recorded diagnosis of hav-
ing more than one allergic disorder. Scaling up
these rates nationally, an estimated 2,312,100
(95%CI 2,299,800–2,324,500) people in England
suffered from multiple allergic disorders in 2005.
Incidence rate of multiple allergic
disorders and changes over time
During the five-year study period the number of
incident cases per 1000 population increased by
32.9% (p<0.001) (Table 2). In 2005, approximately 1
in every 159 people in England was newly diag-
nosed as having multiple allergic disorders.
Consultation rates for any reason for
patients with multiple allergic disorders
In 2005, patients with multiple allergic diseases
consulting a GP (regardless of the reason for con-
sultation) did so an average of 4.9 times (Table 3).
Additionally, these patients consulted a nurse an
average of 2.1 times a year.
Figure 2 compares overall consultation rates for
the whole QRESEARCH population with those for
patients with multiple allergic diseases broken
Figure 1
Lifetime prevalence of multiple allergic disorders per 1000 patients
Table 1
Lifetime prevalence of multiple allergic disorders
Year Age–sex standardized
lifetime prevalence rate
per 1000 patients
95% CI
2001 31.00 30.80–31.21
2002 34.64 34.42–34.85
2003 38.54 38.31–38.76
2004 42.55 42.31–42.78
2005 46.16 45.91–46.40
Table 2
Incidence of multiple allergic disorders
Year Age–sex standardized
lifetime incidence rate
per 1000 patient-years
95% CI
2001 4.72 4.64–4.81
2002 5.21 5.13–5.30
2003 5.59 5.50–5.67
2004 6.21 6.12–6.31
2005 6.28 6.19–6.37
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down by age and sex. This includes all GP and
nurse consultations in 2005 regardless of the
reason for the encounter. Consultation rates for
women tended to be higher than for men and con-
sultation rates for patients with multiple allergic
disorders were higher than overall consultation
rates. For example, for men aged 85–89 years, the
GP and nurse consultation rate for patients with a
diagnosis of multiple allergic disorders was 13.4
(95% CI 13.0–13.7) compared with the overall rate
of 9.1 (95% CI 9.1–9.2) per person.
Figure 3 shows consultations rates per patient
(regardless of the reason for the consultation) for
multiple allergic diseases broken down by age and
sex. The highest consultation rate was 10.1 consul-
tations per person (95% CI 9.9–10.4), which
occurred in women aged 85–89 years.
Number of allergic conditions
experienced
Table 4 shows the number and percentage of
patients in QRESEARCH broken down by the
number of cumulative allergic conditions suffered.
For example, in 2005 there were a total of 2,958,366
registered patients of whom 2,243,128 (75.8%)
patients did not suffer from any allergic conditions
and five patients (0.0002%) suffered from all five
allergic conditions. In 2005, 715,238 patients had at
least one allergic disorder, with 135,497 (18.9%) of
these patients presenting with an additional al-
lergy.
Discussion
This study, using routine data from one of the
world’s largest national data-sets, has revealed
that multiple allergic conditions now commonly
occur in children and adults and that a large in-
crease has occurred in the recorded incidence and
lifetime prevalence of these problems in primary
care in England during the period 2001–2005.
Main strengths and limitations of this
work
The main strengths of this study include our inter-
rogation of an extremely large nationally represen-
tative data-set, the fact that all contributing
practices used the same computing systems for
electronically recording clinical data and the ap-
proach used to ensure that all contributing prac-
tices were accustomed to electronically recording
routine data. The study design employed ensured
that there was no risk of selection bias due to
non-responders or recall bias. Another strength of
this study was the use of contemporaneous clini-
cian recording of a diagnosis of allergic disorders
as opposed to patient self-reporting of historical
diagnoses or symptoms.9,10
There are a number of limitations related to the
use of large routinely collected data from primary
care, including: the dependence on clinician-
recorded diagnosis of allergic disorders and the
possible improvement in recording of allergic dis-
orders over this time period. The relatively short
time window over which trends were studied is
another limitation, but this does also have the ad-
vantage of confining analysis to a period during
which there were no changes in disease definition
or classification. Data regarding childhood preva-
lencemay be underestimated, as the ascertainment
Table 3
Consultation rates for multiple allergic disorders per person per
year by clinician
Year Clinician Age–sex standardized rate
per person per year
95% CI
2001 GP 4.68 4.66–4.62
Nurse 1.57 1.56–1.57
2002 GP 4.73 4.71–4.75
Nurse 1.71 1.70–1.72
2003 GP 4.86 4.84–4.87
Nurse 1.87 1.86–1.87
2004 GP 4.92 4.91–4.93
Nurse 2.00 1.99–2.01
2005 GP 4.90 4.89–4.92
Nurse 2.11 2.10–2.12
Figure 2
Overall consultation rates compared with those for multiple
allergic disorders, for all GP and nurse consultations in 2005
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of disease present in the communitywill be depen-
dent on parents bringing their children for consul-
tation.14 There may have been an underestimate in
the rates of multiple allergic disorders reported.
Firstly, egg and egg-protein allergy (SN580, SN581)
was not included in the final analysis. Secondly, it
has been previously reported that Read codes for
allergy, in particular for food allergies, aremissing,
and therefore some practices may have had diffi-
culties in recording some allergic disease.15
Comparison of findings with other
published work
We found a lower lifetime prevalence of multiple
allergic disorders when compared to the preva-
lence rates found using the HSE (QRESEARCH
database: 0–14 years: 6.0%; 15–45 years: 5.4%; 45+
years 3.3%when compared toHSE: 2–14 years: 9%;
15–44 years: 8%; 45+ years 4%), this most probably
reflecting differences between diagnosed disease
prevalence (electronically recorded in general
practice) and prevalence based on patient recall of
doctor diagnosis, as is the case with the HSE.1
Meaning of the study results: possible
mechanisms and implications for
clinicians and policy-makers
There may be several possible reasons for this
increase in multiple allergic disorders this includ-
ing an increase in sensitization, which would then
in turn predispose the development of any of a
number of allergic disorders. Supporting evidence
for such a possibility comes from an important
study by Law et al. which found significant
increases in atopic sensitization in the UK over a
25-year window.16 Increased predisposition to
atopy,17 possibly reflecting changing exposure to
known and unknown risk factors,18 may also be
important. Increases in the rate of these conditions
could however result from increased clinician
awareness of allergic problems, which may then
have led to improved identification and recording
of allergic disorders. Similarly, increased patient
awareness, or parental awareness of the potential
of accessing effective treatments may have re-
sulted in increased case presentation in primary
care.
The House of Lords Allergy Inquiry published
in 2007 has identified several issues highlighted by
this work and other previous research that require
further attention.19 In particular, given the large
and possibly increasing numbers of people with
multiple allergic problems, there is a need to invest
in improved co-ordinated diagnosis, management
Figure 3
GP consultation rates per patient for multiple allergic disorders
Table 4
Patients in QRESEARCH broken down by number of allergic disorders (n, %)
Year Number of allergic conditions
0 1 2 3 4 5 Total
2001 2,322,895
(81.08)
454,184
(15.85)
77,699
(2.71)
10,067
(0.35)
91
(0.0032)
2
(0.000070)
2,864,938
2002 2,306,006
(79.79)
485,117
(16.79)
87,127
(3.02)
11,821
(0.40)
117
(0.0040)
2
(0.000069)
2,890,190
2003 2,291,287
(78.44)
518,304
(17.74)
97,823
(3.35)
13,594
(0.47)
167
(0.0057)
3
(0. 000103)
2,921,178
2004 2,249,191
(76.97)
549,378
(18.80)
107,666
(3.69)
15,576
(0.53)
209
(0.0072)
4
(0. 000137)
2,922,024
2005 2,243,128
(75.82)
579,741
(19.60)
117,582
(3.98)
17,669
(0.60)
241
(0.0081)
5
(0.000169)
2,958,366
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and support for patients in order to reduce avoid-
able morbidity and inconvenience that many
patients currently experience in moving between
organ-based specialist care providers.
Conclusions and future research
This large national study reveals that the recorded
incidence and lifetime prevalence of patients with
multiple allergic disorders increased in England
during the first half of this decade, which may
reflect a genuine increase in the incidence of mul-
tiple allergic disorders, improved awareness, diag-
nosis and recording in primary care, or, perhaps
most plausibly, a combination of genuine increases
and improved identification and recording. Future
work needs to try and distinguish between these
different possible explanations. A key related im-
portant unanswered question concerns the quality
of care and symptom control of these patients.20
Given the relatively higher prevalence of multiple
allergic problems in childrenwhen comparedwith
adults, the overall numbers of people in England
with multiple allergic problems is, for the present
at least, likely to continue to increase.
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